---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000810693.md"
description: "📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Tempus AI(TEM.US) Tempus AI Launches OneOme Pharmacogenomics Testing Nationwide👉 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:➤  𝗧𝗲𝗺𝗽𝘂𝘀 𝗔𝗜 launches 𝗢𝗻𝗲𝗢𝗺𝗲 pharmacogenomics testing nationwide.➤  Launch follows the company's 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟱 acquisition of OneOme.➤  𝗥𝗶𝗴𝗵𝘁𝗠𝗲𝗱 𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 analyzes 𝟮𝟳 inherited genes.➤  Standalone 𝗗𝗣𝗬𝗗 and 𝗨𝗚𝗧𝟭𝗔𝟭 pharmacogenomics tests are also available.➤  Results are delivered in under 𝟱 days on average.➤  FDA updated fluoropyrimidine safety labeling to recommend 𝗗𝗣𝗬𝗗 testing.➤  Study estimates nearly 𝟯𝟬% of patients experience severe or fatal toxicities.➤  Testing is integrated with Tempus's tissue and liquid biopsy platform.➤  Platform enables clinicians to evaluate 𝗱𝗿𝘂𝗴-𝗴𝗲𝗻𝗲 interactions at the point of care."
datetime: "2026-07-22T12:36:02.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000810693.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000810693.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000810693.md)
author: "[Hardik Shah](https://longbridge.com/en/profiles/27423834.md)"
generator: "portal-rs"
---

# 📢 𝗝𝗨𝗦𝗧 𝗜𝗡: $Tempus AI(TEM.US) Tempus AI Launches O…


### Related Stocks

- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**